Literature DB >> 6958929

Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells.

N H Jones, M J Borowitz, R S Metzgar.   

Abstract

A monoclonal antibody (DU-ALL-1) was generated to common acute lymphoblastic leukemia (cALL) cells by microcytotoxicity and indirect immunofluorescence, DU-ALL-1 reacted only with cALL cell lines and not with the other hematopoietic cell lines tested. Peripheral blood lymphocytes, monocytes, granulocytes and mitogen-activated lymphocytes did not react significantly with this antibody. However, platelets (100%) and normal bone marrow cells (8.5%) reacted with DU-ALL-1. Microcytotoxicity testing of human leukemia cells showed that DU-ALL-1 reacted with cells from a majority of null and pre-B ALL patients (63/77) and with cells from some patients with acute myeloblastic leukemia (4/7) and T-ALL (4/20). DU-ALL-1 was generally non-reactive with cells from patients with B-cell leukemias (2/16) and chronic myelogenous leukemia in blast crisis (0/4). By an indirect immunoperoxidase technique, DU-ALL-1 reacted with a variety of non-hematopoietic tissues, including smooth and cardiac muscle and epithelia from several organs. The DU-ALL-1 antigen had an apparent mol. wt of 24,000 and did not bind to lectins or label with [3H]glucosamine. Thus, DU-ALL-1 defines a 24,000-mol. wt protein which is absent from most peripheral blood mononuclear cells, is expressed on normal platelets and several non-hematopoietic tissues, and may be a useful for subclassifying leukemias.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958929     DOI: 10.1016/0145-2126(82)90002-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding.

Authors:  A de Parseval; D L Lerner; P Borrow; B J Willett; J H Elder
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Immunohistochemical distribution of the tetraspanin CD9 in normal porcine tissues.

Authors:  Noemí Yubero; Angeles Jiménez-Marín; Concepción Lucena; Manuel Barbancho; Juan J Garrido
Journal:  Mol Biol Rep       Date:  2010-06-29       Impact factor: 2.316

3.  Immunohistochemical analysis on normal nephrogenesis and Wilms' tumour using monoclonal antibodies reactive with lymphohaemopoietic antigens.

Authors:  E Ishii; J Fujimoto; S Tanaka; J Hata
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis.

Authors:  S M Hanash; L J Baier; L McCurry; S A Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.

Authors:  M J Borowitz; A Bousvaros; R K Brynes; J B Cousar; J D Crissman; C C Whitcomb; B J Kerns; G E Byrne
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

Review 6.  CD9, a tetraspanin target for cancer therapy?

Authors:  Aurelio Lorico; Marco Lorico-Rappa; Jana Karbanová; Denis Corbeil; Giuseppe Pizzorno
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-18

7.  The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression.

Authors:  Hélène Lazareth; Carole Henique; Olivia Lenoir; Victor G Puelles; Martin Flamant; Guillaume Bollée; Cécile Fligny; Marine Camus; Lea Guyonnet; Corinne Millien; François Gaillard; Anna Chipont; Blaise Robin; Sylvie Fabrega; Neeraj Dhaun; Eric Camerer; Oliver Kretz; Florian Grahammer; Fabian Braun; Tobias B Huber; Dominique Nochy; Chantal Mandet; Patrick Bruneval; Laurent Mesnard; Eric Thervet; Alexandre Karras; François Le Naour; Eric Rubinstein; Claude Boucheix; Antigoni Alexandrou; Marcus J Moeller; Cédric Bouzigues; Pierre-Louis Tharaux
Journal:  Nat Commun       Date:  2019-07-24       Impact factor: 14.919

Review 8.  Tetraspanins: Novel Molecular Regulators of Gastric Cancer.

Authors:  Yue Deng; Sicheng Cai; Jian Shen; Huiming Peng
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

9.  Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.

Authors:  S Ikeyama; M Koyama; M Yamaoko; R Sasada; M Miyake
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.

Authors:  S Higashiyama; R Iwamoto; K Goishi; G Raab; N Taniguchi; M Klagsbrun; E Mekada
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.